Skip to main content
Content Starts Here GSA Federal Advisory Committee Act (FACA) Database Skip to main content

Committee Detail

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.

Details on agency responses to committee recommendations can be found under the Performance Measures section for each committee in the fields “Agency Feedback” and “Agency Feedback Comment.”

HHS - 70466 - Tobacco Products Scientific Advisory Committee - Statutory (Congress Created)


Committee NameTobacco Products Scientific Advisory CommitteeAgency NameDepartment of Health and Human Services
Fiscal Year2022Committee Number70466
Original Establishment Date Committee StatusChartered
Actual Termination Date Committee URL
New Committee This FYNoPresidential Appointments*No
Terminated This FYNoMax Number of Members*12
Current Charter Date8/12/2009Designated Fed Officer Position Title*Designated Federal Officer
Date Of Renewal Charter Designated Federal Officer Prefix
Projected Termination Date Designated Federal Officer First Name*Serina
Exempt From Renewal*YesDesignated Federal Officer Middle NameAmy
Specific Termination AuthorityDesignated Federal Officer Last Name*Hunter-Thomas
Establishment Authority*Statutory (Congress Created)Designated Federal Officer Suffix
Specific Establishment Authority*H.R. 1256 Family Smoking Prevention and Tobacco Control Act; FD&C 21 U.S.C. 387qDesignated Federal Officer Phone*(240) 402-5771
Effective Date Of Authority*6/22/2009Designated Federal Officer Fax*(240)-276-3655
Exempt From EO 13875 Discretionary CmteNot ApplicableDesignated Federal Officer Email*
Committee Type*Continuing
Committee Function*Scientific Technical Program Advisory Board


Agency Recommendation*Continue
Legislation to Terminate RequiredNot Applicable
Legislation StatusNot Applicable
How does cmte accomplish its purpose?*The committee reviews and evaluates safety, dependence, and health issues relating to tobacco products and provides appropriate advice, information and recommendations to the Commissioner of Food and Drugs.
How is membership balanced?*Members are experts in the fields of medicine, medical ethics, science, or technology involving the manufacture, evaluation, or use of tobacco products. One voting member is an officer or employee of a state or local government or of the Federal Government. One voting member is a representative of the general public. In addition to the voting members, the Committee includes 3 non-voting members who are identified with industry interests. These members include one representative of the tobacco manufacturing industry, one representative of the interests of tobacco growers, and one representative of the interests of the small business tobacco manufacturing industry. This final position can be filled on a rotating, sequential basis by representatives of different small business tobacco manufacturers based on areas of expertise relevant to the topics being considered by the Committee.
How frequent & relevant are cmte mtgs?*This committee did not convene any meetings in FY 22 and anticipates holding at least two meetings in FY 23.
Why advice can't be obtained elsewhere?*Members of the committee are drawn from academia, research, and/or clinical practice. Their advice and input lends credibility to regulatory decisions made and helps those decisions stand up to intense public scrutiny. The alternate means of obtaining this advice would be to hire large numbers of scientists on a full time basis at great expense to the government.
Why close or partially close meetings?There were no closed meetings to report in FY 22.
Recommendation RemarksAlthough this committee did not meet in FY 2022, time was devoted to reviewing applications for new nominees, maintaining associated records for these activities, and streamlining paper processes within FDA. In addition, time was spent in the routine care and maintenance of the committee: the development of a financial report for this website; updating the roster and number of vacancies on our website; completing the annual ethics report; reviewing financial disclosures of current members and providing ethics training. Since the Committee did not meet, no reporting was required.


Outcome Improvement To Health Or Safety*YesAction Reorganize Priorities*Yes
Outcome Trust In GovernmentYesAction Reallocate ResourcesNo
Outcome Major Policy ChangesYesAction Issued New RegulationsYes
Outcome Advance In Scientific ResearchYesAction Proposed LegislationNo
Outcome Effective Grant MakingNoAction Approved Grants Or Other PaymentsNo
Outcome Improved Service DeliveryNoAction OtherYes
Outcome Increased Customer SatisfactionYesAction CommentThe Agency will use the committee's advice in implementing the Family Smoking Prevention and Tobacco Control Act.
Outcome Implement Laws/Reg RequirementsYesGrants Review*No
Outcome OtherNoNumber Of Grants Reviewed0
Outcome CommentNANumber Of Grants Recommended0
Cost Savings*Unable to DetermineDollar Value Of Grants Recommended$0.00
Cost Savings CommentThe utilization of the Tobacco Products Scientific Advisory Committee enables the Agency to obtain required and frequently scarce professional services from medical and scientific experts not otherwise available to the Agency and to obtain the services of these experts only on an as needed bases rather than on a full time basis. The service of the committee resulted in advice for the improvement of the public health, for which it is difficult to assign a financial value.Grants Review CommentN/A
Number Of Recommendations*10Access Contact Designated Fed. Officer*Yes
Number Of Recommendations CommentThe committee made 10 recommendations from FY09 through FY22.Access Agency WebsiteYes
% of Recs Fully Implemented*84.00%Access Committee WebsiteYes
% of Recs Fully Implemented CommentThe function of an advisory committee is purely advisory in nature. Although the FDA most often accepts the recommendations from its committees, the advice is purely advisory in nature, and therefore, the Agency has the option of not implementing the advice.Access GSA FACA WebsiteYes
% of Recs Partially Implemented*10.00%Access PublicationsYes
% of Recs Partially Implemented CommentThe function of an advisory committee is purely advisory in nature. Although the FDA most often accepts the recommendations from its committees, the advice is purely advisory in nature, and therefore, the Agency has the option of not implementing the advice.Access OtherNo
Agency Feedback*YesAccess CommentN/A
Agency Feedback Comment*It usually does. Product approval issues are first released to the sponsor. When appropriate, information is made available to the public. Actions related to guidance documents or other general matters or issues are available publicly when implemented. Please see Description*FDA’s strategic priorities in responding to the public health challenges of the 21st century are to advance regulatory science and innovation; strengthen the safety and integrity of the global supply chain; strengthen compliance and enforcement activities to support public health; expand efforts to meet the needs of special populations; advance medical countermeasures and emergency preparedness; advance food safety and nutrition; promote public health by advancing the safety and effectiveness of medical products; establish an effective tobacco regulation, prevention, and control program; and manage for organizational excellence and accountability. The Tobacco Products Scientific Advisory Committee supports FDA's strategic priorities by reviewing and evaluating safety, dependence, and health issues relating to tobacco products and making appropriate recommendations to the Commissioner of Food and Drugs.
Hide Section - COSTS


Payments to Non-Federal Members*$0.00Est Payments to Non-Fed Members Next FY*$15,400.00
Payments to Federal Members*$0.00Est. Payments to Fed Members Next FY*$3,534.00
Payments to Federal Staff*$161,676.00Estimated Payments to Federal Staff*$306,550.00
Payments to Consultants*$0.00Est. Payments to Consultants Next FY*$0.00
Travel Reimb. For Non-Federal Members*$0.00Est Travel Reimb Non-Fed Members nextFY*$18,806.00
Travel Reimb. For Federal Members*$0.00Est Travel Reimb For Fed Members*$0.00
Travel Reimb. For Federal Staff*$0.00Est. Travel Reimb to Fed Staff Next FY*$0.00
Travel Reimb. For Consultants*$0.00Est Travel Reimb to Consultants Next FY*$0.00
Other Costs$40,419.00Est. Other Costs Next FY*$76,638.00
Total Costs$202,095.00Est. Total Next FY*$420,928.00
Date Cost Last Modified9/23/2022 3:59 PMEst. Fed Staff Support Next FY*0.85
Federal Staff Support (FTE)*0.85Est Cost Remarks
Cost Remarks  
Hide Section - Interest Areas

Interest Areas

Health and Health Research


To View all the members, meetings and advisory reports for this committee please click here


No Documents Found



Data from Previous Years

ActionCommittee System IDCommittee NameFiscal Year
 COM-040423Tobacco Products Scientific Advisory Committee2021
 COM-038698Tobacco Products Scientific Advisory Committee2020
 COM-036572Tobacco Products Scientific Advisory Committee2019
 COM-034780Tobacco Products Scientific Advisory Committee2018
 COM-001738Tobacco Products Scientific Advisory Committee2017
 COM-002589Tobacco Products Scientific Advisory Committee2016
 COM-004173Tobacco Products Scientific Advisory Committee2015
 COM-004443Tobacco Products Scientific Advisory Committee2014
 COM-006165Tobacco Products Scientific Advisory Committee2013
 COM-006854Tobacco Products Scientific Advisory Committee2012
 COM-008302Tobacco Products Scientific Advisory Committee2011
 COM-008803Tobacco Products Scientific Advisory Committee2010
 COM-010343Tobacco Products Scientific Advisory Committee2009